مجموعات البحث
Cancer and Leukemia Epigenetics and Biology Program PEBCL
Cancer epigenetics
Manel Esteller
Position at Josep Carreras Institute:
Group leaderCancer genetics
Montse Sanchez-Cespedes
Position at Josep Carreras Institute:
Group leaderChromatin biology laboratory
Alex Vaquero
Position at Josep Carreras Institute:
Group leaderChromatin, metabolism and cell fate
Marcus Buschbeck
Position at Josep Carreras Institute:
Group leader3D chromatin organization
Biola M Javierre
Position at Josep Carreras Institute:
Group leaderEpigenetics and immune disease
Esteban Ballestar
Position at Josep Carreras Institute:
Group leaderLymphocyte development and disease
Maribel Parra
Position at Josep Carreras Institute:
Group leaderRegulatory genomics
Tanya Vavouri
Position at Josep Carreras Institute:
Group leaderRegulatory RNA and chromatin
Sonia Guil
Position at Josep Carreras Institute:
Group leaderEpigenetic control of haematopoiesis
José Luis Sardina
Position at Josep Carreras Institute:
Group leaderTranscriptional dynamics in leukemia
Sergi Cuartero
Position at Josep Carreras Institute:
Group leaderCancer immunogenomics
Eduard Porta
Position at Josep Carreras Institute:
Group leaderCancer heterogeneity and hierarchies
Verónica Rodilla
Position at Josep Carreras Institute:
Group leaderLeukemia and immuno-oncology
Laura Belver
Position at Josep Carreras Institute:
Group leaderCellular systems genomics
Elisabetta Mereu
Position at Josep Carreras Institute:
Group leaderStem cells and cancer
Anna Bigas
Position at Josep Carreras Institute:
Group leaderEndothelial pathobiology and microenvironment
Mariona Graupera
Position at Josep Carreras Institute:
Group leaderT cell lymphoma
Laura Mondragón
Position at Josep Carreras Institute:
Group leaderNuclear Architecture in Leukemia
Gregoire Stik
Position at Josep Carreras Institute:
Group leaderCancer Metabolism
Lucas Pontel
Position at Josep Carreras Institute:
Group leaderExperimental and Clinical Hematology Program PHEC
Acute lymphoblastic leukemia (ALL)
José María Ribera
Position at Josep Carreras Institute:
Group leaderBarcelona Endothelium Team (BET)
Enric Carreras
Position at Josep Carreras Institute:
Group leaderMyeloid neoplasms
Lurdes Zamora
Position at Josep Carreras Institute:
Group leaderImmunohematology and glycobiology
Fumiichiro Yamamoto
Position at Josep Carreras Institute:
Group leaderLymphoid neoplasms
Tomás Navarro
Position at Josep Carreras Institute:
Group leaderMultiple myeloma
Albert Oriol
Position at Josep Carreras Institute:
Group leaderMyelodysplastic syndromes
Francesc Solé
Position at Josep Carreras Institute:
Group leaderStem cell biology, developmental leukemia and immunotherapy
Pablo Menéndez
Position at Josep Carreras Institute:
Group leaderStem cell transplantation and cellular Immunotherapy
Álvaro Urbano-Ispizua
Position at Josep Carreras Institute:
Group leaderEpigenetic therapies
María Berdasco
Position at Josep Carreras Institute:
Group leaderLymphoma translational group
Gaël Roué
Position at Josep Carreras Institute:
Group leaderOncogenesis and antitumor drugs
Ramon Mangues
Position at Josep Carreras Institute:
Group leaderChronic lymphocytic leukemia
Carolina Moreno
Position at Josep Carreras Institute:
Group leaderDescriptive epidemiology and genetics of càncer
Rafael Marcos-Gragera
Position at Josep Carreras Institute:
Group leaderHematology
David Gallardo
Position at Josep Carreras Institute:
Group leaderMyeloid neoplasms - Clínic
Jordi Esteve Reyner
Position at Josep Carreras Institute:
Group leaderHematological diseases, transplant, and cell therapy
Jordi Sierra
Position at Josep Carreras Institute:
Group leaderCellular immunotherapy and gene therapy group
Javier Briones
Position at Josep Carreras Institute:
Group leaderHematological diagnosis
Josep Nomdedéu